-
Featured ArticleApril 05, 2024JAX receives $8 million in federal funding to expand research capacity in rare diseases
The funding will support construction of a dedicated facility for rare disease research, marking the first expansion of the Bar Harbor research footprint in seven years. -
Featured ArticleFebruary 29, 2024Shedding light on common health challenges with rare disease research
In collaboration with Ohio’s Nationwide Children’s Hospital, JAX is testing a gene therapy for PGAP3-Congenital Disorder of Glycosylation (PGAP3-CDG), a rare disease that affects just 65 people worldwide. -
Press ReleaseDecember 19, 2023JAX's 2023 achievements
JAX is celebrating important research breakthroughs, new faculty and leadership appointments, and crucial advancements in legislation. -
Featured ArticleNovember 27, 2023Important new ALS insights
About 5,000 people are diagnosed with ALS each year in the United States, and most people with ALS live for only two to five years after diagnosis.
-
Featured ArticleMarch 26, 2024Hope through novel diagnostics and treatments
Experts from Connecticut's rare disease industry gathered at The Jackson Laboratory for Genomic Medicine on March 7 for The Connecticut Rare Disease Forum. -
Blog PostJanuary 16, 2024Moving genomics-based therapies closer to the clinic
Increasingly powerful research methods and technical capabilities carry important medical implications as genomics-based therapies and cures move ever closer to the clinic. -
Featured ArticleDecember 12, 2023An epic journey into rare disease research
Sarah Holbrook, a Ph.D. candidate at the University of Maine, is wrapping up her time at JAX, a major step in her epic journey in rare disease research. -
Featured ArticleNovember 17, 2023Spreading ALS awareness and changing patient outcomes
Members of the RDTC and Bar Harbor Preclinical Services participated in a walk to raise awareness for ALS.
Education Resources
Jul Aug
22 - 02